HEADER HYDROLASE 13-SEP-02 1O6E TITLE EPSTEIN-BARR VIRUS PROTEASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAPSID PROTEIN P40; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: COAT PROTEIN VP24 (PROTEASE) DOMAIN, RESIDUES 1-235; COMPND 5 SYNONYM: ASSEMBLIN, VIRION STRUCTURAL PROTEIN BVRF2, EC-RF3 AND EC- COMPND 6 RF3A, PROTEASE, CAPSID PROTEIN VP22A; COMPND 7 EC: 3.4.21.97; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN HERPESVIRUS 4; SOURCE 3 ORGANISM_COMMON: HUMAN HERPESVIRUS 4; SOURCE 4 ORGANISM_TAXID: 10376; SOURCE 5 STRAIN: B95-8; SOURCE 6 CELL_LINE: B95-8 MARMOSET CELL LINE; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS PROTEINASE, BETA-BARREL, HYDROLASE, SERINE PROTEASE, STRUCTURAL KEYWDS 2 PROTEOMICS IN EUROPE, SPINE, STRUCTURAL GENOMICS EXPDTA X-RAY DIFFRACTION AUTHOR M.BUISSON,J.HERNANDEZ,D.LASCOUX,G.SCHOEHN,E.FOREST,G.ARLAUD, AUTHOR 2 J.SEIGNEURIN,R.W.H.RUIGROK,W.P.BURMEISTER REVDAT 7 23-OCT-24 1O6E 1 REMARK REVDAT 6 13-DEC-23 1O6E 1 REMARK REVDAT 5 08-MAY-19 1O6E 1 REMARK LINK REVDAT 4 17-AUG-11 1O6E 1 HEADER KEYWDS REMARK FORMUL REVDAT 4 2 1 HETATM VERSN REVDAT 3 24-NOV-09 1O6E 1 VERSN REVDAT 2 24-FEB-09 1O6E 1 VERSN REVDAT 1 14-NOV-02 1O6E 0 JRNL AUTH M.BUISSON,J.HERNANDEZ,D.LASCOUX,G.SCHOEHN,E.FOREST,G.ARLAUD, JRNL AUTH 2 J.SEIGNEURIN,R.W.H.RUIGROK,W.P.BURMEISTER JRNL TITL THE CRYSTAL STRUCTURE OF THE EPSTEIN-BARR VIRUS PROTEASE JRNL TITL 2 SHOWS REARRANGEMENT OF THE PROCESSED C TERMINUS JRNL REF J.MOL.BIOL. V. 324 89 2002 JRNL REFN ISSN 0022-2836 JRNL PMID 12421561 JRNL DOI 10.1016/S0022-2836(02)01040-9 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 0.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 24212 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1149 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.38 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1813 REMARK 3 BIN R VALUE (WORKING SET) : 0.3860 REMARK 3 BIN FREE R VALUE : 0.3820 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 91 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.038 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3483 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 14 REMARK 3 SOLVENT ATOMS : 12 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 56.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 66.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.95000 REMARK 3 B22 (A**2) : -8.95000 REMARK 3 B33 (A**2) : 17.90000 REMARK 3 B12 (A**2) : -7.30000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.35 REMARK 3 ESD FROM SIGMAA (A) : 0.70 REMARK 3 LOW RESOLUTION CUTOFF (A) : 42.0 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.41 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.64 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.700 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.200 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.930 ; 2.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 5.020 ; 3.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.000 ; 4.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.770 ; 4.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.31 REMARK 3 BSOL : 26.60 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : PARAM.DFP REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : TOPH3.DFP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINED USING THE TWINNED TARGET, REMARK 3 TWINNING FRACTION 0.477, OPERATOR -H,-K,L THE REFINEMENT HAS REMARK 3 BEEN CARRIED OUT AGAINST TWINNED DATA USING THE CORRESPONDING REMARK 3 TARGET IN CNS. R-FACTORS CAN NOT DIRECTLY BE COMPARED TO THE REMARK 3 ONES FROM UNTWINNED STRUCTURES. FOR MAP CALCULATIONS, A REMARK 3 DIFFERENT DATASET WITH A TWINNING FRACTION MORE DIFFERENT FROM REMARK 3 0.5 HAS BEEN USED. ITS RESOLUTION WAS LIMITED TO 2.5 A. SOME REMARK 3 REGIONS CARACTERISED BY B FACTORS ABOVE 90 A2 ARE POORLY DEFINED. REMARK 4 REMARK 4 1O6E COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 13-SEP-02. REMARK 100 THE DEPOSITION ID IS D_1290011400. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUN-01 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 4.60 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.919 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : TOROIDAL MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 132854 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 45.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 5.400 REMARK 200 R MERGE (I) : 0.08100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 5.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 0.31900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1FL1 REMARK 200 REMARK 200 REMARK: CRYSTAL TWINNED REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.57 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: HANGING DROP METHOD USING A RESERVOIR REMARK 280 SOLUTION OF 1.25 - 1.5 M SODIUM FORMATE,100 MM SODIUM CITRATE REMARK 280 PH4.6 5 MM EDTA, PROTEIN IN 100 MM NACL 20 MM THRIS-HCL PH 7.5 1 REMARK 280 MM EDTA 10 MM BETA-MERCAPTOETHANOL, PH 4.60, VAPOR DIFFUSION, REMARK 280 HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 110.16667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 220.33333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 220.33333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 110.16667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8520 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 41340 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -52.8 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 110.16667 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED MUTATION ARG 64 SER, CHAINS A AND B REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 VAL A 2 REMARK 465 GLN A 3 REMARK 465 GLU A 187 REMARK 465 SER A 188 REMARK 465 GLY A 189 REMARK 465 CYS A 190 REMARK 465 PRO A 191 REMARK 465 GLU A 192 REMARK 465 ASP A 193 REMARK 465 MET B 1 REMARK 465 VAL B 2 REMARK 465 GLN B 3 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLY B 146 NH2 ARG B 149 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 19 C - N - CA ANGL. DEV. = 9.1 DEGREES REMARK 500 PRO A 20 C - N - CA ANGL. DEV. = 9.1 DEGREES REMARK 500 LYS A 39 N - CA - C ANGL. DEV. = -26.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 29 -15.94 -49.93 REMARK 500 LEU A 36 -149.30 53.62 REMARK 500 PRO A 37 -119.04 -61.32 REMARK 500 LYS A 39 -123.02 -125.83 REMARK 500 PRO A 41 158.66 -45.25 REMARK 500 ILE A 85 -36.79 -35.73 REMARK 500 ARG A 101 137.34 -34.41 REMARK 500 PRO A 103 -96.95 -29.87 REMARK 500 ALA A 129 26.81 -50.98 REMARK 500 ASP A 130 31.51 36.34 REMARK 500 LEU A 145 105.34 -165.47 REMARK 500 THR A 152 109.20 -42.96 REMARK 500 HIS A 165 -14.74 -49.37 REMARK 500 SER A 167 -75.77 -58.34 REMARK 500 ASP A 168 0.71 -49.31 REMARK 500 LYS A 185 7.46 -55.04 REMARK 500 PRO A 195 -76.06 -18.09 REMARK 500 LEU A 196 82.83 148.80 REMARK 500 PRO A 197 72.84 -39.90 REMARK 500 TYR A 232 32.65 -98.65 REMARK 500 LYS A 234 0.32 -68.58 REMARK 500 LEU B 36 -136.42 30.54 REMARK 500 PRO B 37 -143.38 -78.19 REMARK 500 LEU B 38 60.99 -64.37 REMARK 500 LYS B 39 -72.88 -57.58 REMARK 500 PRO B 103 -98.92 -34.71 REMARK 500 PRO B 122 -9.97 -48.54 REMARK 500 ASP B 123 126.02 2.51 REMARK 500 ILE B 124 -48.91 114.68 REMARK 500 GLN B 126 138.78 44.10 REMARK 500 THR B 128 82.21 -155.54 REMARK 500 ALA B 129 72.18 -49.93 REMARK 500 ASP B 130 60.25 31.99 REMARK 500 LEU B 145 118.84 -174.16 REMARK 500 LYS B 185 8.07 -58.45 REMARK 500 SER B 188 -119.29 -71.45 REMARK 500 HIS B 194 79.55 171.46 REMARK 500 PRO B 195 -78.70 -1.52 REMARK 500 LEU B 196 114.24 152.31 REMARK 500 PRO B 197 66.82 -57.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ISP A 1236 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ISP B 1236 REMARK 999 REMARK 999 SEQUENCE REMARK 999 ONLY PROTEASE DOMAIN OF THE ASSEMBLIN IS PRESENT REMARK 999 IN THE CRYSTAL.THE SEQUENCE IS MODIFIED AT THE REMARK 999 N-TERMINUS DUE TO THE INTRODUCTION OF A THROMBIN REMARK 999 CLEAVAGE SITE. DBREF 1O6E A 1 235 UNP P03234 PPR_EBVB9 1 235 DBREF 1O6E B 1 235 UNP P03234 PPR_EBVB9 1 235 SEQADV 1O6E SER A 64 UNP P03234 ARG 64 ENGINEERED MUTATION SEQADV 1O6E SER B 64 UNP P03234 ARG 64 ENGINEERED MUTATION SEQRES 1 A 235 MET VAL GLN ALA PRO SER VAL TYR VAL CYS GLY PHE VAL SEQRES 2 A 235 GLU ARG PRO ASP ALA PRO PRO LYS ASP ALA CYS LEU HIS SEQRES 3 A 235 LEU ASP PRO LEU THR VAL LYS SER GLN LEU PRO LEU LYS SEQRES 4 A 235 LYS PRO LEU PRO LEU THR VAL GLU HIS LEU PRO ASP ALA SEQRES 5 A 235 PRO VAL GLY SER VAL PHE GLY LEU TYR GLN SER SER ALA SEQRES 6 A 235 GLY LEU PHE SER ALA ALA SER ILE THR SER GLY ASP PHE SEQRES 7 A 235 LEU SER LEU LEU ASP SER ILE TYR HIS ASP CYS ASP ILE SEQRES 8 A 235 ALA GLN SER GLN ARG LEU PRO LEU PRO ARG GLU PRO LYS SEQRES 9 A 235 VAL GLU ALA LEU HIS ALA TRP LEU PRO SER LEU SER LEU SEQRES 10 A 235 ALA SER LEU HIS PRO ASP ILE PRO GLN THR THR ALA ASP SEQRES 11 A 235 GLY GLY LYS LEU SER PHE PHE ASP HIS VAL SER ILE CYS SEQRES 12 A 235 ALA LEU GLY ARG ARG ARG GLY THR THR ALA VAL TYR GLY SEQRES 13 A 235 THR ASP LEU ALA TRP VAL LEU LYS HIS PHE SER ASP LEU SEQRES 14 A 235 GLU PRO SER ILE ALA ALA GLN ILE GLU ASN ASP ALA ASN SEQRES 15 A 235 ALA ALA LYS ARG GLU SER GLY CYS PRO GLU ASP HIS PRO SEQRES 16 A 235 LEU PRO LEU THR LYS LEU ILE ALA LYS ALA ILE ASP ALA SEQRES 17 A 235 GLY PHE LEU ARG ASN ARG VAL GLU THR LEU ARG GLN ASP SEQRES 18 A 235 ARG GLY VAL ALA ASN ILE PRO ALA GLU SER TYR LEU LYS SEQRES 19 A 235 ALA SEQRES 1 B 235 MET VAL GLN ALA PRO SER VAL TYR VAL CYS GLY PHE VAL SEQRES 2 B 235 GLU ARG PRO ASP ALA PRO PRO LYS ASP ALA CYS LEU HIS SEQRES 3 B 235 LEU ASP PRO LEU THR VAL LYS SER GLN LEU PRO LEU LYS SEQRES 4 B 235 LYS PRO LEU PRO LEU THR VAL GLU HIS LEU PRO ASP ALA SEQRES 5 B 235 PRO VAL GLY SER VAL PHE GLY LEU TYR GLN SER SER ALA SEQRES 6 B 235 GLY LEU PHE SER ALA ALA SER ILE THR SER GLY ASP PHE SEQRES 7 B 235 LEU SER LEU LEU ASP SER ILE TYR HIS ASP CYS ASP ILE SEQRES 8 B 235 ALA GLN SER GLN ARG LEU PRO LEU PRO ARG GLU PRO LYS SEQRES 9 B 235 VAL GLU ALA LEU HIS ALA TRP LEU PRO SER LEU SER LEU SEQRES 10 B 235 ALA SER LEU HIS PRO ASP ILE PRO GLN THR THR ALA ASP SEQRES 11 B 235 GLY GLY LYS LEU SER PHE PHE ASP HIS VAL SER ILE CYS SEQRES 12 B 235 ALA LEU GLY ARG ARG ARG GLY THR THR ALA VAL TYR GLY SEQRES 13 B 235 THR ASP LEU ALA TRP VAL LEU LYS HIS PHE SER ASP LEU SEQRES 14 B 235 GLU PRO SER ILE ALA ALA GLN ILE GLU ASN ASP ALA ASN SEQRES 15 B 235 ALA ALA LYS ARG GLU SER GLY CYS PRO GLU ASP HIS PRO SEQRES 16 B 235 LEU PRO LEU THR LYS LEU ILE ALA LYS ALA ILE ASP ALA SEQRES 17 B 235 GLY PHE LEU ARG ASN ARG VAL GLU THR LEU ARG GLN ASP SEQRES 18 B 235 ARG GLY VAL ALA ASN ILE PRO ALA GLU SER TYR LEU LYS SEQRES 19 B 235 ALA HET ISP A1236 7 HET ISP B1236 7 HETNAM ISP PHOSPHORYLISOPROPANE FORMUL 3 ISP 2(C3 H9 O4 P) FORMUL 5 HOH *12(H2 O) HELIX 1 1 ASP A 28 LEU A 36 1 9 HELIX 2 2 SER A 75 SER A 80 1 6 HELIX 3 3 SER A 80 HIS A 87 1 8 HELIX 4 4 CYS A 89 SER A 94 1 6 HELIX 5 5 GLU A 102 LEU A 112 1 11 HELIX 6 6 ASP A 158 HIS A 165 1 8 HELIX 7 7 GLU A 170 LYS A 185 1 16 HELIX 8 8 PRO A 197 ALA A 208 1 12 HELIX 9 9 ASN A 213 ALA A 225 1 13 HELIX 10 10 ASP B 28 LEU B 36 1 9 HELIX 11 11 SER B 75 SER B 80 1 6 HELIX 12 12 SER B 80 HIS B 87 1 8 HELIX 13 13 CYS B 89 SER B 94 1 6 HELIX 14 14 GLU B 102 LEU B 112 1 11 HELIX 15 15 ASP B 158 HIS B 165 1 8 HELIX 16 16 GLU B 170 LYS B 185 1 16 HELIX 17 17 PRO B 197 ALA B 208 1 12 HELIX 18 18 ARG B 214 ALA B 225 1 12 SHEET 1 AA 7 SER A 114 LEU A 120 0 SHEET 2 AA 7 PHE A 136 CYS A 143 -1 O PHE A 136 N LEU A 120 SHEET 3 AA 7 LEU A 42 VAL A 46 1 O PRO A 43 N VAL A 140 SHEET 4 AA 7 LEU A 49 GLN A 62 -1 N LEU A 49 O VAL A 46 SHEET 5 AA 7 LEU A 67 ILE A 73 -1 O PHE A 68 N TYR A 61 SHEET 6 AA 7 VAL A 7 GLU A 14 -1 O VAL A 7 N ILE A 73 SHEET 7 AA 7 VAL A 154 GLY A 156 -1 O VAL A 154 N CYS A 10 SHEET 1 BA 7 SER B 114 LEU B 120 0 SHEET 2 BA 7 PHE B 136 CYS B 143 -1 O PHE B 136 N LEU B 120 SHEET 3 BA 7 LEU B 42 VAL B 46 1 O PRO B 43 N VAL B 140 SHEET 4 BA 7 LEU B 49 TYR B 61 -1 N LEU B 49 O VAL B 46 SHEET 5 BA 7 LEU B 67 ILE B 73 -1 O PHE B 68 N TYR B 61 SHEET 6 BA 7 VAL B 7 GLU B 14 -1 O VAL B 7 N ILE B 73 SHEET 7 BA 7 VAL B 154 GLY B 156 -1 O VAL B 154 N CYS B 10 LINK OG SER A 116 P ISP A1236 1555 1555 1.58 LINK OG SER B 116 P ISP B1236 1555 1555 1.56 SITE 1 AC1 8 LEU A 25 HIS A 48 SER A 116 LEU A 117 SITE 2 AC1 8 ILE A 124 GLY A 146 ARG A 147 ARG A 148 SITE 1 AC2 7 HIS B 48 SER B 116 LEU B 117 ALA B 118 SITE 2 AC2 7 GLY B 146 ARG B 147 HOH B2006 CRYST1 52.800 52.800 330.500 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018939 0.010935 0.000000 0.00000 SCALE2 0.000000 0.021869 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003026 0.00000 MTRIX1 1 -0.999300 0.023900 0.028500 7.30000 1 MTRIX2 1 0.035500 0.845000 0.533600 -13.89000 1 MTRIX3 1 -0.011300 0.534200 -0.845300 47.02000 1